Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Q3 2018 Earnings Conference Call Transcript
Nov 06, 2018 • 04:30 pm ET
Greetings and welcome to the Paratek Pharmaceuticals' Third Quarter 2018 Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to turn the call over to your host, Ben Strain, Executive Director of IR and Corporate Communications for Paratek Pharmaceuticals. Ben, please go ahead.
Good afternoon and welcome to Paratek's Third Quarter 2018 Earnings and Corporate Update Conference Call. A press release for the company's third quarter results was issued earlier today and we have also posted slides on our website that will be referred to on this call. Both can be found at www.paratekpharma.com. Participants on today's call are Michael Bigham, CEO and Chairman of the Board; Douglas Pagan, CFO; Adam Woodrow, Chief Commercial Officer; and Evan Loh, President, COO and Chief Medical Officer will also be available for Q&A. (Forward-Looking Cautionary Statements) Michael?